These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1100 related items for PubMed ID: 30102687

  • 1. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
    Jiang Y, Xu B, Chen J, Sui Y, Ren L, Li J, Zhang H, Guo L, Sun X.
    Med Sci Monit; 2018 Aug 13; 24():5635-5644. PubMed ID: 30102687
    [Abstract] [Full Text] [Related]

  • 2. Long non-coding RNA 00507/miRNA-181c-5p/TTBK1/MAPT axis regulates tau hyperphosphorylation in Alzheimer's disease.
    Yan Y, Yan H, Teng Y, Wang Q, Yang P, Zhang L, Cheng H, Fu S.
    J Gene Med; 2020 Dec 13; 22(12):e3268. PubMed ID: 32891070
    [Abstract] [Full Text] [Related]

  • 3. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
    Liu W, Zhao J, Lu G.
    Biochem Biophys Res Commun; 2016 Sep 16; 478(2):852-7. PubMed ID: 27520374
    [Abstract] [Full Text] [Related]

  • 4. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice.
    Zhou D, Liu H, Li C, Wang F, Shi Y, Liu L, Zhao X, Liu A, Zhang J, Wang C, Chen Z.
    Metab Brain Dis; 2016 Jun 16; 31(3):693-703. PubMed ID: 26883430
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
    Liu CG, Wang JL, Li L, Wang PC.
    Int J Mol Med; 2014 Jul 16; 34(1):160-6. PubMed ID: 24827165
    [Abstract] [Full Text] [Related]

  • 6. Huannao Yicong decoction ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by interfering with neurotoxic interaction of Aβ-tau.
    Zhang H, Chen W, Li Z, Huang Q, Wen J, Chang S, Pei H, Ma L, Li H.
    J Ethnopharmacol; 2024 Jan 10; 318(Pt B):116985. PubMed ID: 37532075
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X, Kosaraju J, Zhou W, Tam KY.
    ACS Chem Neurosci; 2017 Mar 15; 8(3):676-685. PubMed ID: 28032988
    [Abstract] [Full Text] [Related]

  • 8. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
    Peng Y, Hu Y, Xu S, Li P, Li J, Lu L, Yang H, Feng N, Wang L, Wang X.
    J Alzheimers Dis; 2012 Mar 15; 29(2):379-91. PubMed ID: 22233765
    [Abstract] [Full Text] [Related]

  • 9. HDAC6 modulates the cognitive behavioral function and hippocampal tissue pathological changes of APP/PS1 transgenic mice through HSP90-HSF1 pathway.
    Wang B, Liu S, Hao K, Wang Y, Li Z, Lou Y, Chang Y, Qi W.
    Exp Brain Res; 2024 Aug 15; 242(8):1983-1998. PubMed ID: 38935089
    [Abstract] [Full Text] [Related]

  • 10. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease.
    Wu X, Kosaraju J, Zhou W, Tam KY.
    Neuropharmacology; 2018 Mar 15; 131():351-363. PubMed ID: 29309769
    [Abstract] [Full Text] [Related]

  • 11. HDAC3 negatively regulates spatial memory in a mouse model of Alzheimer's disease.
    Zhu X, Wang S, Yu L, Jin J, Ye X, Liu Y, Xu Y.
    Aging Cell; 2017 Oct 15; 16(5):1073-1082. PubMed ID: 28771976
    [Abstract] [Full Text] [Related]

  • 12. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
    Wang D, Fei Z, Luo S, Wang H.
    Curr Neurovasc Res; 2020 Oct 15; 17(1):93-101. PubMed ID: 32003672
    [Abstract] [Full Text] [Related]

  • 13. [Age-dependent expression of HSP90 in the hippocampus of APP/PS1 mice].
    Wang BY, Liu SY, Hao KM, Qi WX.
    Sheng Li Xue Bao; 2024 Apr 25; 76(2):257-265. PubMed ID: 38658375
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin.
    Li F, Wei G, Bai Y, Li Y, Huang F, Lin J, Hou Q, Deng R, Zhou JH, Zhang SX, Chen DF.
    Brain Res; 2015 Nov 19; 1627():177-88. PubMed ID: 26423933
    [Abstract] [Full Text] [Related]

  • 15. Silencing the ACAT1 Gene in Human SH-SY5Y Neuroblastoma Cells Inhibits the Expression of Cyclo-Oxygenase 2 (COX2) and Reduces β-Amyloid-Induced Toxicity Due to Activation of Protein Kinase C (PKC) and ERK.
    Chen Y, Zhu L, Ji L, Yang Y, Lu L, Wang X, Zhou G.
    Med Sci Monit; 2018 Dec 12; 24():9007-9018. PubMed ID: 30541014
    [Abstract] [Full Text] [Related]

  • 16. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation.
    Bao XQ, Li N, Wang T, Kong XC, Tai WJ, Sun H, Zhang D.
    PLoS One; 2013 Dec 12; 8(11):e78033. PubMed ID: 24223757
    [Abstract] [Full Text] [Related]

  • 17. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
    Zhang ZX, Zhao RP, Wang DS, Wang AN.
    Exp Gerontol; 2016 Nov 12; 84():88-95. PubMed ID: 27612601
    [Abstract] [Full Text] [Related]

  • 18. Thamnolia vermicularis extract improves learning ability in APP/PS1 transgenic mice by ameliorating both Aβ and Tau pathologies.
    Li C, Guo XD, Lei M, Wu JY, Jin JZ, Shi XF, Zhu ZY, Rukachaisirikul V, Hu LH, Wen TQ, Shen X.
    Acta Pharmacol Sin; 2017 Jan 12; 38(1):9-28. PubMed ID: 27694908
    [Abstract] [Full Text] [Related]

  • 19. Simvastatin ameliorate memory deficits and inflammation in clinical and mouse model of Alzheimer's disease via modulating the expression of miR-106b.
    Huang W, Li Z, Zhao L, Zhao W.
    Biomed Pharmacother; 2017 Aug 12; 92():46-57. PubMed ID: 28528185
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of miR-26a-5p Suppresses Tau Phosphorylation and Aβ Accumulation in the Alzheimer's Disease Mice by Targeting DYRK1A.
    Liu Y, Wang L, Xie F, Wang X, Hou Y, Wang X, Liu J.
    Curr Neurovasc Res; 2020 Aug 12; 17(3):241-248. PubMed ID: 32286945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.